Windtree Therapeutics Stock News

Northern Trust Corp increased its position in shares of Windtree Therapeutics, Inc. (NASDAQ:WINT) by 28.8% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 65,380 shares of the companys stock after buying an additional 14,637 shares during the quarter. Northern Trust Corps holdings in Windtree [] The post Northern Trust Corp Grows Position in Windtree Therapeutics, Inc. (NASDAQ:WINT) appeared first on ETF Daily News .

This strategy identified LGVN stock a month ago, and now its price has skyrocketed. Here are two more biotechs that could do the same.

Tuesday, October 19th @ 8:00 am Eastern Time Tuesday, October 19th @ 8:00 am Eastern Time

Cardiogenic Shock Worldwide Total Market Value Is Estimated To Be $1.25 Billion Cardiogenic Shock Worldwide Total Market Value Is Estimated To Be $1.25 Billion

WARRINGTON, Pa., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for

The stock price of Windtree Therapeutics Inc (NASDAQ: WINT) increased by over 50% pre-market. These are some details you should know.

WARRINGTON, Pa., July 08, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for a

WARRINGTON, Pa., July 07, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for a

The stock price of Windtree Therapeutics Inc (NASDAQ: WINT) increased by 36.36% on Friday, June 4. This is why it happened.

Meme penny stocks are in focus right now, what are they, and which small-caps are investors watching? The post Meme Penny Stocks, What Are They, and 3 to Watch Right Now appeared first on Penny Stocks

Windtree Therapeutics Inc (NASDAQ:WINT) shares are trading higher by 32% at $2.63 in Friday's premarket session after Oppenheimer initiated coverage on the stock with an Outperform rating and an $8�

Insider buying could be a bullish sign for a stock. Insiders may sell their shares for many reasons.

Wall Street recommends buying shares of NeuroBo Pharmaceuticals Inc (NASDAQ:NRBO) and Windtree Therapeutics Inc (NASDAQ:WINT), even though these two securities have shown poor performance over the pri

WARRINGTON, Pa., Nov. 16, 2020 /PRNewswire/ -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute